New drug trial aims to help people walk and move again after spinal cord injury
NCT ID NCT05965700
Summary
This study is testing an investigational drug called NVG-291 to see if it can help improve nerve signaling and function in people with spinal cord injuries. It will enroll 40 adults with recent (subacute) or long-term (chronic) cervical spinal cord injuries to measure changes in walking speed, hand strength, and other movement abilities. The main goals are to check the drug's safety and see if it helps restore some nerve connections and physical function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shirley Ryan AbilityLab
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.